Literature DB >> 18472921

Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice.

A C Knulst1, G J Tibbe, C Bril-Bazuin, E G Breedland, A van Oudenaren, R Benner, H F Savelkoul.   

Abstract

A murine model for acute lethal graft vs. host disease (GVHD) was used to study the role that a number of cytokines play in the development of lethal GVHD. In this study we focused on the role of IL-1, IL-2, IL-4, IL-6, IFN-gamma and TNF-alpha. Lethally irradiated (C57BL x CBA)F1 mice were reconstituted either with 10(7) allogeneic BALB/c spleen cells or with a similar number of syngeneic cells, as a control. A significant rise in serum levels of IL-6, TNF-alpha and IFN-gamma levels was found in allogeneically reconstituted mice. This is in contrast to the syngeneic control group in which no rise was seen. Serum IL-2 and IL-4 levels were below the detection limit. In the supernatant of Con A stimulated spleen cells from allogeneically reconstituted mice IL-6, IFN-gamma and TNF-alpha concentrations were increased. The expression of mRNA for cytokines as detected by reverse transcription PCR was studied in spleen cells. In the allogeneic reconstituted mice the mRNA expression of IL-1alpha, IL-2, IL-6, IFN-gamma and TNF-alpha displayed faster kinetics compared with that in syngeneic reconstituted mice. The effect of treatment with recombinant cytokines, antibodies to cytokines and to cytokine receptors on the development of GVHD was investigated. Administration of recombinant IL-2 to allogeneically reconstituted mice strongly increased the morbidity and mortality whereas injection of IL-1alpha and TNF-alpha did not influence survival. Administration of antibodies against IL-2 or the IL-2 receptor decreased the morbidity and mortality. Anti-IL-6, anti-IFN-gamma, and anti-TNF-alpha mAB, on the other hand, did not affect the morbidity and mortality of GVHD. The results of this study suggest successive waves of cytokine-secreting cell populations consistent with the induction of an inflammatory response in the development of acute GVH disease.

Entities:  

Year:  1994        PMID: 18472921      PMCID: PMC2367011          DOI: 10.1155/S0962935194000062

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  33 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  Detection and quantitation of cells secreting IL-6 under physiologic conditions in BALB/c mice.

Authors:  A Shirai; K Holmes; D Klinman
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

3.  Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.

Authors:  J L Ferrara; S Abhyankar; D G Gilliland
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Preferential activation of Th2 cells in chronic graft-versus-host reaction.

Authors:  D De Wit; M Van Mechelen; C Zanin; J M Doutrelepont; T Velu; C Gérard; D Abramowicz; J P Scheerlinck; P De Baetselier; J Urbain
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Mediatory role of stem cell derived cells in LPS-induced splenic CFUs accumulation.

Authors:  W J Molendijk; R E Ploemacher; M E Erkens-Versluis
Journal:  Exp Hematol       Date:  1982-07       Impact factor: 3.084

7.  Production of hybridoma growth factor by human monocytes.

Authors:  L A Aarden; E R De Groot; O L Schaap; P M Lansdorp
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

8.  Interleukin-8 serum concentrations after liver transplantation.

Authors:  H Tilg; M Ceska; W Vogel; M Herold; R Margreiter; C Huber
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

9.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.